RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS INITIATING BIOLOGICS/APREMILAST FOR PSORIATIC ARTHRITIS: A NATIONWIDE POPULATION-BASED STUDY USING THE FRENCH HEALTH INSURANCE DATABASE

被引：0
|
作者：
Vegas, L. Pina [1 ,2 ]
Le Corvoisier, P. [3 ,4 ]
Penso, L. [1 ,5 ]
Paul, M. [1 ,6 ]
Sbidian, E. [1 ,4 ,7 ]
Claudepierre, P. [1 ,2 ]
机构：
[1] Univ Paris Est Creteil, Epiderme, Creteil, France
[2] Hop Henri Mondor, Rhumatol, Creteil, France
[3] Univ Paris Est Creteil, INSERM, Ecole Natl Vet Alfort, U955 IMRB,Equipe 03, Creteil, France
[4] Hop Henri Mondor, Ctr Invest Clin 1430, INSERM, Creteil, France
[5] EPI PHARE Sci Interest Grp Epidemiol Hlth Prod, French Natl Agcy Safety Med & Hlth Prod, French Natl Hlth Insurance, St Denis, France
[6] Hop Henri Mondor, Pharm, Creteil, France
[7] Hop Henri Mondor, Dermatol, Creteil, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.287
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0201
引用
收藏
页码：317 / 317
页数：1
相关论文
共 50 条
  • [1] Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
    Vegas, Laura Pina
    Le Corvoisier, Philippe
    Penso, Laetitia
    Paul, Muriel
    Sbidian, Emilie
    Claudepierre, Pascal
    RHEUMATOLOGY, 2022, 61 (04) : 1589 - 1599
  • [2] Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
    Ouyang, Fengchen
    RHEUMATOLOGY, 2022, 61 (10) : E320 - E320
  • [3] Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study: Reply
    Vegas, Laura Pina
    Claudepierre, Pascal
    Sbidian, Emilie
    RHEUMATOLOGY, 2022, 61 (08) : E238 - E239
  • [4] Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study: Reply
    Pina Vegas, Laura
    Claudepierre, Pascal
    Sbidian, Emilie
    RHEUMATOLOGY, 2022, 61 (10) : E321 - E322
  • [5] Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study
    Ogdie, Alexis
    Yu, YiDing
    Haynes, Kevin
    Love, Thorvardur Jon
    Maliha, Samantha
    Jiang, Yihui
    Troxel, Andrea B.
    Hennessy, Sean
    Kimmel, Steven E.
    Margolis, David J.
    Choi, Hyon
    Mehta, Nehal N.
    Gelfand, Joel M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 326 - 332
  • [6] The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study
    Yen, Tsai-Hung
    Chen, Yun-Wen
    Hsieh, Tsu-Yi
    Chen, Yi-Ming
    Huang, Wen-Nan
    Chen, Yi-Hsing
    Chen, Hsin-Hua
    RHEUMATOLOGY, 2023, 63 (08) : 2074 - 2081
  • [7] Factors associated with risk of major adverse cardiovascular events in patients with rheumatoid arthritis: a nationwide, population-based, case-control study
    Chen, Yen-Ju
    Liu, Shih-Chia
    Lai, Kuo-Lung
    Tang, Kuo-Tung
    Lin, Ching-Heng
    Chen, Yi-Ming
    Tseng, Chih-Wei
    Chang, Yu-Mei
    Gotcher, Donald F.
    Chiou, Chuang-Chun
    Weng, Shao-Jen
    Chen, Hsin-Hua
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [8] Rates of major adverse cardiovascular events (MACE) and revascularization among patients with psoriasis or psoriatic arthritis treated with apremilast, biologics, DMARDs, and corticosteroids in the US MarketScan database
    Persson, Rebecca
    Hagberg, Katrina W.
    Qian, Ellen
    Vasilakis-Scaramozza, Catherine
    Niemcryk, Steve
    Peng, Michael
    Paris, Maria
    Lindholm, Anders
    Jick, Susan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 474 - 474
  • [9] Comment on: The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study
    Chen, Fang-Yu
    Huo, An-Ping
    Wei, James Cheng-Chung
    RHEUMATOLOGY, 2024, 63 (08) : e236 - e236
  • [10] Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
    Peluso, Rosario
    Caso, Francesco
    Tasso, Marco
    Ambrosino, Pasquale
    Di Minno, Matteo Nicola Dario
    Lupoli, Roberta
    Criscuolo, Livio
    Caso, Paolo
    Ursini, Francesco
    Del Puente, Antonio
    Scarpa, Raffaele
    Costa, Luisa
    REVIEWS ON RECENT CLINICAL TRIALS, 2018, 13 (03) : 199 - 209
12345